Search by Drug Name or NDC

    NDC 41163-0546-63 equaline complete 800; 10; 165 mg/1; mg/1; mg/1 Details

    equaline complete 800; 10; 165 mg/1; mg/1; mg/1

    equaline complete is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Supervalu Inc. The primary component is CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 41163-0546
    Product ID 41163-546_1f2ed065-778d-498d-ac66-711a7b47699e
    Associated GPIs 49993503300520
    GCN Sequence Number 047669
    GCN Sequence Number Description famotidine/Ca carb/mag hydrox TAB CHEW 10-800-165 ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 13069
    HICL Sequence Number 021332
    HICL Sequence Number Description FAMOTIDINE/CALCIUM CARBONATE/MAGNESIUM HYDROXIDE
    Brand/Generic Generic
    Proprietary Name equaline complete
    Proprietary Name Suffix dual action
    Non-Proprietary Name Famotidine, Calcium Carbonate, Magnesium Hydroxide
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, CHEWABLE
    Route ORAL
    Active Ingredient Strength 800; 10; 165
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
    Labeler Name Supervalu Inc
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Elect
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077355
    Listing Certified Through 2023-12-31

    Package

    NDC 41163-0546-63 (41163054663)

    NDC Package Code 41163-546-63
    Billing NDC 41163054663
    Package 25 TABLET, CHEWABLE in 1 BOTTLE (41163-546-63)
    Marketing Start Date 2008-09-02
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 728e0a46-fcad-424e-bbf0-20f2797022ca Details

    Revised: 7/2022